person · Reporting owner

BARTHELEMY NICOLAS

Disclosed activity across 4 companies

Tapewire entity: 46693
SEC CIK: 0001283576

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
REPLIGEN CORPRGEN · Entity 486	Director	May 14, 2026	May 18, 2026
STANDARD BIOTOOLS INC.FLDM · Entity 6116	Director	April 01, 2022	April 04, 2022
Twist Bioscience CorpTWST · Entity 3619	Director	November 21, 2022	November 23, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

REPLIGEN CORP

Report date May 14, 2026 · Filed May 18, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	5,436	Reported balance After 2026-05-14 transaction · row 1 1 source row Row 1 · 2026-05-14 · Grant · Acquired 995 · Balance 5,436 F1: Mr. Barthelemy was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $103.38 · Expires 2036-05-14	Direct	2,239	Reported balance After 2026-05-14 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-05-14 · Grant · Acquired 2,239 · Balance 2,239 F2: Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Filing footnotes · ownership attribution and instrument terms

F1: Mr. Barthelemy was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

F2: Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

STANDARD BIOTOOLS INC.

Report date April 01, 2022 · Filed April 04, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectThe Barthelemy 2001 Trust	204,077	Reported balance After 2022-04-01 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2022-04-01 · Exercise / conversion · Acquired 20,993 · Balance 204,077
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.74 · Expires 2030-06-23	Direct	0	Reported balance After 2022-04-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-04-01 · Exercise / conversion · Disposed 20,993 · Balance 0

Twist Bioscience Corp

Report date November 21, 2022 · Filed November 23, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	23,021	Reported balance After 2022-11-21 transaction · row 1 1 source row Row 1 · 2022-11-21 · Exercise / conversion · Acquired 9,082 · Balance 23,021
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.33 · Expires 2029-10-23	Direct	11,279	Reported balance After 2022-11-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-11-21 · Exercise / conversion · Disposed 9,082 · Balance 11,279 F1: 1/3 of the shares subject to the option vest and become exercisable on the first anniversary of October 24, 2020, and 1/3rd of the shares subject to the option vest and become exercisable on each anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: 1/3 of the shares subject to the option vest and become exercisable on the first anniversary of October 24, 2020, and 1/3rd of the shares subject to the option vest and become exercisable on each anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

908 Devices Inc.

Report date June 15, 2022 · Filed June 17, 2022

Section 16 reporting ended · disclosed 2022-06-17. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.001SEC Table I · non-derivative	Direct	15,379	Reported balance After 2022-06-15 transaction · row 1 1 source row Row 1 · 2022-06-15 · Exercise / conversion · Acquired 1,379 · Balance 15,379 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-06-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-06-15 · Exercise / conversion · Disposed 1,379 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3: The RSUs became fully vested on June 15, 2022, the day prior to the 2022 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date.
Common Stock, par value $0.001SEC Table I · non-derivative	IndirectSee Footnote	13,541	Reported balance Holding disclosure · report date 2022-06-15 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 13,541 F2: These securities are owned directly by The Barthelemy 2001 Trust. The reporting person and his spouse are trustees of The Barthelemy 2001 Trust and have joint voting and dispositive control with respect to all securities held by The Barthelemy 2001 Trust and may be deemed to be the beneficial owner of the securities held by The Barthelemy 2001 Trust.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.

F2: These securities are owned directly by The Barthelemy 2001 Trust. The reporting person and his spouse are trustees of The Barthelemy 2001 Trust and have joint voting and dispositive control with respect to all securities held by The Barthelemy 2001 Trust and may be deemed to be the beneficial owner of the securities held by The Barthelemy 2001 Trust.

F3: The RSUs became fully vested on June 15, 2022, the day prior to the 2022 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 23, 2020 Filed Jun 25, 2020 19:59 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	GrantStock Option (Right to Buy) · Derivative	20,993	$0.00 Strike: $3.74	$0.00	Disclosure SEC source: 0001162194-20-000082 · wf-form4_159311513151361.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,993 Underlying: Common Stock · 20,993 shares Expires 2030-06-23 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 23, 2020. Read SEC document
June 23, 2020 Filed Jun 25, 2020 19:59 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	GrantCommon Stock	13,369	$0.00	$0.00	Disclosure SEC source: 0001162194-20-000082 · wf-form4_159311513151361.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 165,242 F1 · shares: The Restricted Stock Units vest in full on the earlier to occur of June 23, 2021 and one day prior to the date of the Company's next annual meeting of stockholders. Read SEC document
May 18, 2020 Filed May 27, 2020 01:24 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionStock Option (Right to Buy) · Derivative	2,109	$0.00 Strike: $67.71	$0.00	Disclosure SEC source: 0000899243-20-014280 · doc4.xml · derivative · entry 3 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable. Read SEC document
May 18, 2020 Filed May 27, 2020 01:24 UTC	REPLIGEN CORP RGEN · Entity 486	SaleCommon Stock	3,009	$142.53	$428,872.77	Disclosure SEC source: 0000899243-20-014280 · doc4.xml · nonDerivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,664 Read SEC document
May 18, 2020 Filed May 27, 2020 01:24 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionCommon Stock	2,109	$67.71	$142,800.39	Disclosure SEC source: 0000899243-20-014280 · doc4.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 13, 2020 Filed May 20, 2020 00:42 UTC	REPLIGEN CORP RGEN · Entity 486	GrantStock Option (Right to Buy) · Derivative	1,285	$0.00 Strike: $128.18	$0.00	Disclosure SEC source: 0000899243-20-013633 · doc4.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285 Underlying: Common Stock · 1,285 shares Expires 2030-05-13 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 13, 2021. Read SEC document
May 13, 2020 Filed May 20, 2020 00:42 UTC	REPLIGEN CORP RGEN · Entity 486	GrantCommon Stock	527	$0.00	$0.00	Disclosure SEC source: 0000899243-20-013633 · doc4.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,564 F1 · shares: Mr. Barthelemy was awarded 527 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 13, 2021. The restricted stock unit may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance. Read SEC document
April 22, 2020 Filed Apr 24, 2020 21:22 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionStock Option (Right to Buy) · Derivative	1,652	$0.00 Strike: $42.07	$0.00	Disclosure SEC source: 0000899243-20-011304 · doc4.xml · derivative · entry 3 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,652 shares Expires 2028-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document
April 22, 2020 Filed Apr 24, 2020 21:22 UTC	REPLIGEN CORP RGEN · Entity 486	SaleCommon Stock	2,688	$109.99	$295,653.12	Disclosure SEC source: 0000899243-20-011304 · doc4.xml · nonDerivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,037 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on February 28, 2020. Read SEC document
April 22, 2020 Filed Apr 24, 2020 21:22 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionCommon Stock	1,652	$42.07	$69,499.64	Disclosure SEC source: 0000899243-20-011304 · doc4.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 03, 2020 Filed Apr 6, 2020 23:34 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionStock Option (Right to Buy) · Derivative	1,652	$0.00 Strike: $42.07	$0.00	Disclosure SEC source: 0000899243-20-010341 · doc4.xml · derivative · entry 3 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652 Underlying: Common Stock · 1,652 shares Expires 2028-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document
April 03, 2020 Filed Apr 6, 2020 23:34 UTC	REPLIGEN CORP RGEN · Entity 486	SaleCommon Stock	2,688	$99.99	$268,773.12	Disclosure SEC source: 0000899243-20-010341 · doc4.xml · nonDerivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,073 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on February 28, 2020. Read SEC document
April 03, 2020 Filed Apr 6, 2020 23:34 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionCommon Stock	1,652	$42.07	$69,499.64	Disclosure SEC source: 0000899243-20-010341 · doc4.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 23, 2020 Filed Mar 25, 2020 21:25 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionRestricted Stock Units · Derivative	2,500	$0.00	$0.00	Disclosure SEC source: 0001162194-20-000030 · wf-form4_158517149180597.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units vesting as to 25% of the shares underlying the Restricted Stock Units on each anniversary date after the date of grant on the same day of the month as the date of grant, subject to continued service as a director. F2 · derivative.expiration_date: On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units vesting as to 25% of the shares underlying the Restricted Stock Units on each anniversary date after the date of grant on the same day of the month as the date of grant, subject to continued service as a director. Read SEC document
March 23, 2020 Filed Mar 25, 2020 21:25 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionCommon Stock	2,500	$0.00	$0.00	Disclosure SEC source: 0001162194-20-000030 · wf-form4_158517149180597.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 151,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 06, 2020 Filed Mar 10, 2020 22:59 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	PurchaseCommon Stock	80,000	$3.05	$243,872.00	Disclosure SEC source: 0001162194-20-000018 · wf-form4_158388118238096.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 149,373 F1 · price: The range of prices for the transactions reported is between $3.005 and $3.10 per share. $3.0484 represents the weighted average purchase price per share. Reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document
February 13, 2020 Filed Feb 19, 2020 01:33 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	PurchaseCommon Stock	12,257	$3.64	$44,614.25	Disclosure SEC source: 0001162194-20-000005 · wf-form4_158207600428502.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 69,373 F1 · price: The range of prices for the transaction reported is between $3.635 and $3.64 per share. $3.6399 represents the weighted average purchase price per share. Reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document
February 04, 2020 Filed Feb 7, 2020 00:00 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	GrantCommon Stock	15,267	$0.00	$0.00	Disclosure SEC source: 0001162194-20-000004 · wf-form4_158103363906460.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 57,116 F1 · shares: Represents Restricted Stock Units that vest in four equal quarterly installments beginning March 31, 2020. Read SEC document
February 04, 2020 Filed Feb 6, 2020 21:24 UTC	Twist Bioscience Corp TWST · Entity 3619	GrantDirector Stock Option (right to buy) · Derivative	5,648	$0.00 Strike: $26.20	$0.00	Disclosure SEC source: 0001214659-20-001012 · marketforms-47698.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,648 Underlying: Common Stock · 5,648 shares Expires 2030-02-03 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document
February 04, 2020 Filed Feb 6, 2020 21:24 UTC	Twist Bioscience Corp TWST · Entity 3619	GrantCommon Stock	1,412	$0.00	$0.00	Disclosure SEC source: 0001214659-20-001012 · marketforms-47698.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,412 F1 · shares: Represents a restricted stock unit award (the "RSU Award") of which 100% vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document
February 04, 2020 Filed Mar 5, 2021 16:40 UTC Amendment	Twist Bioscience Corp TWST · Entity 3619	GrantDirector Stock Option (right to buy) · Derivative	11,297	$0.00 Strike: $26.20	$0.00	Disclosure SEC source: 0001214659-21-002794 · marketforms-51436.xml · derivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,297 Underlying: Common Stock · 11,297 shares Expires 2030-02-03 F1 · shares: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. F1 · derivative.underlying_shares: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. F1 · balance_after: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. Read SEC document
October 24, 2019 Filed Oct 28, 2019 16:52 UTC	Twist Bioscience Corp TWST · Entity 3619	GrantDirector Stock Option (right to buy) · Derivative	14,573	$0.00 Strike: $23.33	$0.00	Disclosure SEC source: 0001209191-19-054257 · doc4.xml · derivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,573 Underlying: Common Stock · 14,573 shares Expires 2029-10-23 F1 · derivative.exercise_date: 1/3rd of the shares subject to the option vest and become exercisable on October 24, 2020, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document
October 24, 2019 Filed Mar 5, 2021 16:30 UTC Amendment	Twist Bioscience Corp TWST · Entity 3619	GrantDirector Stock Option (right to buy) · Derivative	25,361	$0.00 Strike: $23.33	$0.00	Disclosure SEC source: 0001214659-21-002780 · marketforms-51444.xml · derivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,361 Underlying: Common Stock · 25,361 shares Expires 2029-10-23 F1 · shares: The Form 4 originally filed on October 28, 2019 incorrectly reported 14,573 options. F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vest and become exercisable on October 24, 2020, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. F1 · derivative.underlying_shares: The Form 4 originally filed on October 28, 2019 incorrectly reported 14,573 options. F1 · balance_after: The Form 4 originally filed on October 28, 2019 incorrectly reported 14,573 options. Read SEC document
June 17, 2019 Filed Jun 19, 2019 20:36 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	SaleCommon Stock	5,100	$12.43	$63,397.59	Disclosure SEC source: 0001162194-19-000058 · wf-form4_156097658559616.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 41,849 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2019. F2 · price: The range of prices for the transactions reported is between $12.27 and $12.62 per share. $12.4309 represents the weighted average sale price per share. The reporting person will provide full information regarding the number of shares sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document
June 03, 2019 Filed Jun 5, 2019 17:42 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	GrantStock Option (Right to Buy) · Derivative	6,796	$0.00 Strike: $13.41	$0.00	Disclosure SEC source: 0001162194-19-000054 · wf-form4_155975650850831.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,796 Underlying: Common Stock · 6,796 shares Expires 2029-06-03 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 3, 2019. Read SEC document
June 03, 2019 Filed Jun 5, 2019 17:42 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	GrantCommon Stock	3,987	$0.00	$0.00	Disclosure SEC source: 0001162194-19-000054 · wf-form4_155975650850831.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 46,949 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 3, 2020 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document
May 15, 2019 Filed May 17, 2019 20:10 UTC	REPLIGEN CORP RGEN · Entity 486	GrantStock Option (Right to Buy) · Derivative	2,109	$0.00 Strike: $67.71	$0.00	Disclosure SEC source: 0000899243-19-013991 · doc4.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 15, 2020. Read SEC document
May 15, 2019 Filed May 17, 2019 20:10 UTC	REPLIGEN CORP RGEN · Entity 486	GrantCommon Stock	923	$0.00	$0.00	Disclosure SEC source: 0000899243-19-013991 · doc4.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,109 F1 · shares: Mr. Barthelemy was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document
March 23, 2019 Filed Mar 26, 2019 21:49 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionRestricted Stock Units · Derivative	2,500	$0.00	$0.00	Disclosure SEC source: 0001162194-19-000024 · wf-form4_155363697683449.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director. F2 · derivative.expiration_date: On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director. Read SEC document
March 23, 2019 Filed Mar 26, 2019 21:49 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionCommon Stock	2,500	$0.00	$0.00	Disclosure SEC source: 0001162194-19-000024 · wf-form4_155363697683449.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 42,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionStock Option (Right to Buy) · Derivative	1,992	$0.00 Strike: $41.19	$0.00	Disclosure SEC source: 0000899243-18-023645 · doc4.xml · derivative · entry 5 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,992 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionStock Option (Right to Buy) · Derivative	2,434	$0.00 Strike: $38.76	$0.00	Disclosure SEC source: 0000899243-18-023645 · doc4.xml · derivative · entry 4 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,434 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC	REPLIGEN CORP RGEN · Entity 486	SaleCommon Stock	6,580	$54.44	$358,196.12	Disclosure SEC source: 0000899243-18-023645 · doc4.xml · nonDerivative · entry 3 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,186 F1 · price: $54.4371 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.39 to $54.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionCommon Stock	1,992	$41.19	$82,050.48	Disclosure SEC source: 0000899243-18-023645 · doc4.xml · nonDerivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 29, 2018 Filed Aug 31, 2018 20:15 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionCommon Stock	2,434	$38.76	$94,341.84	Disclosure SEC source: 0000899243-18-023645 · doc4.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 31, 2018 Filed Jun 2, 2018 00:56 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	GrantStock Option (Right to Buy) · Derivative	10,600	$0.00 Strike: $5.57	$0.00	Disclosure SEC source: 0001162194-18-000077 · wf-form4_152790094756793.xml · derivative · entry 6 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,600 Underlying: Common Stock · 10,600 shares Expires 2028-05-31 F5 · derivative.exercise_date: 1/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on May 31, 2019. Read SEC document
May 31, 2018 Filed Jun 2, 2018 00:56 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	GrantCommon Stock	6,100	$0.00	$0.00	Disclosure SEC source: 0001162194-18-000077 · wf-form4_152790094756793.xml · nonDerivative · entry 3 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 40,462 F1 · security: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · shares: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) May 31, 2019, in each case subject to recipient's continued service as a director through the applicable vest date. Read SEC document
May 30, 2018 Filed Jun 2, 2018 00:56 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionRestricted Stock Units · Derivative	3,000	$0.00	$0.00	Disclosure SEC source: 0001162194-18-000077 · wf-form4_152790094756793.xml · derivative · entry 5 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. F4 · derivative.expiration_date: On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. Read SEC document
May 30, 2018 Filed Jun 2, 2018 00:56 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionRestricted Stock Units · Derivative	5,000	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001162194-18-000077 · wf-form4_152790094756793.xml · derivative · entry 4 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. F3 · derivative.expiration_date: On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. Read SEC document
May 30, 2018 Filed Jun 2, 2018 00:56 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionCommon Stock	3,000	$0.00	$0.00	Disclosure SEC source: 0001162194-18-000077 · wf-form4_152790094756793.xml · nonDerivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 34,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 30, 2018 Filed Jun 2, 2018 00:56 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionCommon Stock	5,000	$0.00	$0.00	Disclosure SEC source: 0001162194-18-000077 · wf-form4_152790094756793.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 31,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 16, 2018 Filed May 17, 2018 20:42 UTC	REPLIGEN CORP RGEN · Entity 486	GrantStock Option (Right to Buy) · Derivative	3,304	$0.00 Strike: $42.07	$0.00	Disclosure SEC source: 0001140361-18-024445 · doc1.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,304 Underlying: Common Stock · 3,304 shares Expires 2028-05-16 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 16, 2019. Read SEC document
May 16, 2018 Filed May 17, 2018 20:42 UTC	REPLIGEN CORP RGEN · Entity 486	GrantCommon Stock	1,486	$0.00	$0.00	Disclosure SEC source: 0001140361-18-024445 · doc1.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,340 F1 · shares: Mr. Barthelemy was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document
May 09, 2018 Filed May 11, 2018 14:38 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionStock Option (Right to Buy) · Derivative	3,366	$0.00 Strike: $26.12	$0.00	Disclosure SEC source: 0001140361-18-022910 · doc1.xml · derivative · entry 5 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,366 shares Expires 2026-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document
May 09, 2018 Filed May 11, 2018 14:38 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionStock Option (Right to Buy) · Derivative	24,000	$0.00 Strike: $20.37	$0.00	Disclosure SEC source: 0001140361-18-022910 · doc1.xml · derivative · entry 4 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2024-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document
May 09, 2018 Filed May 11, 2018 14:38 UTC	REPLIGEN CORP RGEN · Entity 486	SaleCommon Stock	26,500	$40.54	$1,074,238.45	Disclosure SEC source: 0001140361-18-022910 · doc1.xml · nonDerivative · entry 3 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,854 F1 · price: $40.5373 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.22 to $40.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document
May 09, 2018 Filed May 11, 2018 14:38 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionCommon Stock	3,366	$26.12	$87,919.92	Disclosure SEC source: 0001140361-18-022910 · doc1.xml · nonDerivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 09, 2018 Filed May 11, 2018 14:38 UTC	REPLIGEN CORP RGEN · Entity 486	Exercise / conversionCommon Stock	24,000	$20.37	$488,880.00	Disclosure SEC source: 0001140361-18-022910 · doc1.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 23, 2018 Filed Mar 27, 2018 00:57 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionRestricted Stock Units · Derivative	2,500	$0.00	$0.00	Disclosure SEC source: 0001162194-18-000043 · wf-form4_152211220176276.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units, of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest on each anniversary after the date of grant on the same day of the month as the date of grant until fully vested, subject to continued service as a director through each such date. F2 · derivative.expiration_date: On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units, of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest on each anniversary after the date of grant on the same day of the month as the date of grant until fully vested, subject to continued service as a director through each such date. Read SEC document
March 23, 2018 Filed Mar 27, 2018 00:57 UTC	STANDARD BIOTOOLS INC. FLDM · Entity 6116	Exercise / conversionCommon Stock	2,500	$0.00	$0.00	Disclosure SEC source: 0001162194-18-000043 · wf-form4_152211220176276.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Barthelemy 2001 Trust Disclosed balance after: 26,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.